Close
0
You have no items in your order cart.
Search
Filters

Equine Vaccines

View as Grid List
Sort by
Display per page

Equilis Prequenza Te - 10 x 1ml

107681
Active immunisation of horses from 6 months of age against equine influenza to reduce clinical signs and virus excretion after infection, and active immunisation against tetanus to prevent mortality.

Influenza:
Onset of immunity - 2 weeks after primary vaccination course
Duration of immunity - 5 months after them primary vaccination course. 12 months after the first revaccination

Tetanus:
Onset of immunity - 2 weeks after the primary vaccination course
Duration of immunity - 17 months after the primary vaccination course. 24 months after the first revaccination

Revaccination
Influenza
The first revaccination (third dose) against equine influenza is given 5 months after the primary vaccination course. This revaccination results in immunity to equine influenza lasting at least 12 months. The second revaccination is given 12 months after the first revaccination. The alternate use, at 12 months interval, of a suitable vaccine against equine influenza, containing the strains A/equine-2/South Africa/4/03 and A/equine-2/Newmarket-2/93, is recommended to maintain immunity levels for the influenza component.

Tetanus
The first revaccination is given not later than 17 months after the primary vaccination course. Thereafter a maximum interval of two years is recommended.

Equilis Prequenza Te - 5 x 1ml

107671
Active immunisation of horses from 6 months of age against equine influenza to reduce clinical signs and virus excretion after infection, and active immunisation against tetanus to prevent mortality.

Influenza:
Onset of immunity - 2 weeks after primary vaccination course
Duration of immunity - 5 months after them primary vaccination course. 12 months after the first revaccination

Tetanus:
Onset of immunity - 2 weeks after the primary vaccination course
Duration of immunity - 17 months after the primary vaccination course. 24 months after the first revaccination

Revaccination
Influenza
The first revaccination (third dose) against equine influenza is given 5 months after the primary vaccination course. This revaccination results in immunity to equine influenza lasting at least 12 months. The second revaccination is given 12 months after the first revaccination. The alternate use, at 12 months interval, of a suitable vaccine against equine influenza, containing the strains A/equine-2/South Africa/4/03 and A/equine-2/Newmarket-2/93, is recommended to maintain immunity levels for the influenza component.

Tetanus
The first revaccination is given not later than 17 months after the primary vaccination course. Thereafter a maximum interval of two years is recommended.

Equilis Te - 10 x 1ml

120291
Active immunisation of horses from 6 months of age against tetanus to prevent mortality.

Onset of immunity: 2 weeks after the primary vaccination course.

Duration of immunity: 17 months after the primary vaccination course, 24 months after the first revaccination.

Equip EHV 1.4 - 1.5ml x 1

197870
For active immunisation of horses to reduce clinical signs due to infection with Equine Herpesvirus 1 and 4 and to reduce abortion caused by EHV-1 infection.

Dosage and administration
One dose per horse to be administered by deep intramuscular injection.

Primary course
A single dose should be administered from 5 months of age followed by a second injection after an interval of 4-6 weeks.

In the event of increased infection risk, for example when a foal has consumed insufficient colostrum or there is a risk of early exposure to field infections with EHV-1 or EHV-4, earlier vaccination may be given. In these circumstances the foal should receive a single dose from 3 months of age followed by the above mentioned full primary vaccination course.

Booster
Following completion of the primary course, a single dose should be administered every 6 months.

Use in pregnant mares:
To reduce abortion due to EHV-1 infection, pregnant mares should be vaccinated during the 5th, 7th and 9th month of pregnancy with a single 1.5 ml dose on each occasion.

Equip Rotavirus - 10 x 1ml

146434
For the vaccination of pregnant mares to provide passive transfer of antibodies to foals to reduce the risk of diarrhoea caused by equine rotavirus G3 P12 serotypes. Mares are able to transfer the passive immunity to the foals 4 weeks after the third vaccination. Foals of the vaccinated mares show an increase in antibodies against equine rotavirus for approximately sixty days.

Dosage and administration
1.0 ml dose per mare to be administered by deep intramuscular injection.

Vaccination Schedule
Pregnant mares should be given three doses of vaccine consisting of a single 1ml dose administered at the 8th, 9th and 10th month of each pregnancy.

ProteqFlu (Richmond) - 10 x 1ml

123984
Active immunisation of horses of 4 months of age or older against equine influenza to reduce clinical signs and virus excretion after infection.

Onset of immunity: 14 days after primary vaccination course.

Duration of immunity induced by the vaccination scheme: 5 months after primary vaccination course and 1 year after the third vaccination.

Dosage and administration
For intramuscular use.
1st scheme – vaccination against equine influenza:
Administer one dose (1 ml of ProteqFlu), by intramuscular injection, preferably in the neck region, according to the following schedule:

- Primary vaccination course: first injection from 5–6 months of age, second injection 4–6 weeks later.
- Revaccination: 5 months after primary vaccination course followed by annual booster injections.
<>BRIn case of increased infection risk or insufficient colostrum intake, an additional initial injection of ProteqFlu can be given at the age of 4 months followed by the full vaccination programme (primary vaccination course at 5–6 months of age and 4–6 weeks later followed by revaccination).

2nd scheme - vaccination against equine influenza and tetanus:
Administer one dose (1 ml), by intramuscular injection, preferably in the neck region, according to the following schedule:
- primary vaccination course with ProteqFlu-Te: first injection from 5–6 months of age, second injection 4–6 weeks later.

- Revaccination:
· 5 months after primary vaccination course with ProteqFlu-Te.
- Followed by:
· against tetanus: injection of 1 dose at an interval of maximum 2 years with ProteqFlu-Te.
· against equine influenza: injection of 1 dose every year, alternatively with ProteqFlu or ProteqFlu-Te, respecting an interval of maximum 2 years for the tetanus component. In case of increased infection risk or insufficient colostrum intake, an additional initial injection of ProteqFlu-Te can be given at the age of 4 months followed by the full vaccination programme (primary vaccination course at 5–6 months of age and 4–6 weeks later followed by revaccination).

ProteqFlu-Te - 10 x 1ml

123994
Active immunisation of horses of 4 months of age or older against equine influenza to reduce clinical signs and virus excretion after infection, and against tetanus to prevent mortality.

Onset of immunity: 14 days after primary vaccination course.

Duration of immunity induced by the vaccination scheme:
- 5 months after the primary vaccination course
- After the primary vaccination course and the booster injection 5 months later: 1 year with regard to equine influenza and 2 years with regard to tetanus.

Dosage and administration
For intramuscular use.
For administration of the vaccine, use sterile and antiseptic-free and/or disinfectant-free material. Shake the vaccine gently before use.

Administer one dose (1 ml), by intramuscular injection, preferably in the neck region, according to the following schedule:
- primary vaccination course with ProteqFlu-Te: first injection from 5–6 months of age, second injection 4–6 weeks later.

Revaccination:
· 5 months after primary vaccination course with ProteqFlu-Te.

Followed by:
· against tetanus: injection of 1 dose at an interval of maximum 2 years with ProteqFlu-Te.
· against equine influenza: injection of 1 dose every year, alternatively with ProteqFlu or ProteqFlu-Te, respecting an interval of maximum 2 years for the tetanus component.

In case of increased infection risk or insufficient colostrum intake, an additional initial injection of ProteqFlu-Te can be given at the age of 4 months followed by the full vaccination programme (primary vaccination course at 5–6 months of age and 4–6 weeks later followed by revaccination).

Tetanus Antitoxin - 50ml

115170
An anti-serum against Clostridium tetani for use in horses, sheep and dogs. Tetanus Antitoxin Behring is intended for prophylactic use in horses, sheep and dogs to reduce the risk of tetanus infection as a result of accidental injury or as a preoperative precaution. Tetanus Antitoxin Behring is intended for therapeutic use in horses and dogs to increase the recovery rates in animals suffering from clinical tetanus.

After subcutaneous and intramuscular injection of Tetanus Antitoxin Behring, maximum serological titres are reached within 2 days. The titre slowly decreases with time, but the protective effect lasts for between 2 and 3 weeks.

After intravenous injection, maximum serological titres are reached within three hours and decrease slowly at a similar rate to that following subcutaneous or intramuscular injection. After subarachnoidal injection effective titres in the central nervous system are reached straight after application. The duration of effective antibody titres has not been investigated in the central nervous system. The intravenous and subarachnoidal application routes are recommended for therapeutic use of Tetanus Antitoxin Behring in horses only.